⭐️ Excellent #AACR26 abstract breakdown of 🔑 abstracts for #CommunityOncology by the @OncBrothers

Back to meeting Original

Back to meeting

x.com· @ · X·2026-04-23 06:16· 2026-04-23Score60

RMC-9805

Reading

KRAS / RAS targeting: from platform to Phase 3

zoldonrasib and VS-7375 in G12D remain Phase 1 — strong numbers, small samples, not head-to-head.

Body

⭐️ Excellent #AACR26 abstract breakdown of 🔑 abstracts for #CommunityOncology by the @OncBrothers

⭐️#CM77T
⭐️#TRUST
⭐️#RMC-9805-001
⭐️#LB407
⭐️#LB337

#Onctwitter #MedTwitter #MedX @AACR #gism #lcsm #FOAMed #MedEd #Oncology
#KRAS #CancerResearch #Cancer #NSCLC

Heat 13 · 9 likes · 0 replies · 4 reposts

Conference abstracts

LB407NCT05379985 NCT06445062matched by 摘要号 LB407

Daraxonrasib plus chemotherapy (CT) as first-line (1L) treatment for patients (Pts) with metastatic pancreatic adenocarcinoma (mPDAC)

Brian M. Wolpin, Benjamin L. Musher, Gulam A. Manji, Wungki Park, Alexander Spira, Nilofer Azad, Vaia Florou, Tiago Biachi De Castria, Mark H. O'Hara, Erkut Borazanci, Aparna Parikh, John Strickler, Joel Randolph Hecht, Shubham Pant, Shiraj Sen, E. Gabriela Chiorean, W. Clay Gustafson, Hina Patel, Vidya Seshadri, Yan Zheng, Davendra Sohal

Read the abstract →

LB337NCT05379985matched by 摘要号 LB337

Daraxonrasib monotherapy as first-line (1L) treatment for patients with metastatic pancreatic adenocarcinoma (mPDAC)

Eileen M. O'Reilly, Brian Wolpin, Shubham Pant, Joel Randolph Hecht, Jennifer Valerin, Dae Won Kim, Nilofer Azad, Kyaw Aung, Lin Tao, Sumit Kar, Hina Patel, Rashmi Vora, Aparna Hegde, Alexander Spira, Alexander Starodub, Benjamin Herzberg, Ignacio Garrido-Laguna

Read the abstract →

Source: x.com · x.com